Superiority of Enoxaparin Over Heparin in Combination With a GPIIb/IIIa Receptor Antagonist During Coronary Thrombolysis in Dogs

Author： Rebello S.S.   Kasiewski C.J.   Bentley R.G.   Morgan S.R.   Chu V.   Bostwick J.S.   Klein S.I.   Perrone M.H.   Leadley R.J.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.102, Iss.3, 2001-05, pp. : 261-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EFFECTS OF TAK-029, A NOVEL GPIIb/IIIa ANTAGONIST, ON ARTERIAL THROMBOSIS IN GUINEA PIGS, DOGS AND MONKEYS

By Kawamura M.   Tsuji N.   Moriya N.   Terashita Z.-i.  

Thrombosis Research, Vol. 86, Iss. 4, 1997-05 ,pp. : 275-285

Elsevier

Access to resources Recommend Favorite

Oral Antiplatelet Efficacy of the Platelet GPIIb/IIIa Antagonist, DMP754 in Non-Human Primates - Receptor binding affinity & specificity

By Mousa S.A.   Bozarth J.   Youssef A.   Levine B.  

Thrombosis Research, Vol. 89, Iss. 5, 1998-03 ,pp. : 217-225

Elsevier

Access to resources Recommend Favorite

Bleeding Risk of Tirofiban, a Nonpeptide GPIIb/IIIa Platelet Receptor Antagonist in Progressive Stroke: An Open Pilot Study

By  

Cerebrovascular Diseases, Vol. 12, Iss. 4, 2001-11 ,pp. : 308-312

Karger

Access to resources Recommend Favorite

Intranasal Antiplatelet/ Antithrombotic Efficacy of a Novel Platelet GPIIB/IIIA Receptor Antagonist DMP755 - a model for in vivo evaluation of antithrombotic agents

By Mousa S.A.   Mu D.-X.   Hussain M.A.  

Thrombosis Research, Vol. 92, Iss. 3, 1998-11 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Platelet GPIIb/IIIa Receptor Antagonists in Human Ischemic Brain Disease

By  

Current Vascular Pharmacology, Vol. 6, Iss. 1, 2008-01 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite